Navigation Links
Biotage Launches New 24 Well Pyrosequencing(R) System
Date:3/31/2008

Next Generation Pyrosequencing(R) System; PyroMark(TM)Q24 Pyrosequencing

Technology in a 24 Well Format for Low Throughput Epigenetic Studies

UPPSALA, Sweden, March 31 /PRNewswire/ -- Pyrosequencing AB, a subsidiary of Biotage AB today announced the launch of PyroMark(TM)Q24 the latest in the range of Pyrosequencing(R) Systems. This new high-performance platform includes a complete software package for the study of genetic and epigenetic variation of genes, providing CpG methylation allele quantification and mutation analysis. These studies are used for a wide range of clinical research, for example the identification and tracking of changes involved in various forms of cancer. Studying these changes using Pyrosequencing(R) technology, which is based on the principals of sequencing by synthesis, is an ideal choice for genetic analysis in clinical research. The output information is based on real sequence data providing integrated quality control and security in the quality of the results.

The system, aimed at lower throughput needs, optimizes the management of fewer samples. The 24 well plate format and the ability to run and analyze both mutation and methylation assays on the same plate provides an ideal solution for managing low sample numbers or mixed analysis needs while providing the accuracy, flexibility and convenience offered by Pyrosequencing(R) technology.

Until now Pyrosequencing(R) technology has only been available in higher throughput systems, placing it out of the reach of many researchers. "With the introduction of the new PyroMark(TM)Q24 system we plan to open up the availability of Pyrosequencing(R) technology to many more researchers." Said Torben Jorgensen President and CEO of Biotage AB.

The PyroMark(TM)Q24 performance has been successfully demonstrated at sites in the US and Europe. Pyromark(TM)Q24 was shown to provide reproducible and reliable results at the Dept of Pathology, Uppsala University Hospital for clinical diagnostics in oncology.

According to Jakob Lindmark VP Sales and Marketing for Biosystems unit at Biotage the PyroMark(TM)Q24 is the first in a series of solutions for different applications in this lower throughput format.

About Biotage

Biotage is a global company active in life science research with strong technologies, a broad range of operations and a long-term view of the market. The company offers solutions, knowledge and experience in the areas of genetic analysis and medicinal chemistry. In 2005 operations and products were acquired from the American company Argonaut, further strengthening the medicinal chemistry product range. The customers include the world's top 30 pharmaceutical companies, the world's top 20 biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has offices in the U.S., Japan, UK, Germany and several other European countries. Biotage has 336 employees and had sales of 496,4 MSEK in 2007. Biotage is listed on the OMX Nordic Exchange Stockholm AB. Website: http://www.biotage.com

Contact:

Jakob Lindmark

VP Sales and Marketing for Biosystems

Tel: +46-706-566022

Jakob.lindmark@eu.biotage.com

Biotage AB

Kungsgatan 76

SE-753 18 Uppsala

Tel: +46-18-56-59-00


'/>"/>
SOURCE Biotage AB
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract
2. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
3. Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
4. BioElectronics Launches 1 Day Breast Augmentation Recovery Kit
5. Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord
6. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
7. Moleac Launches NeuroAid10(TM) in the United States
8. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
9. MultiVu Video Feed: Johnson & Johnson Diabetes Institute, LLC Launches New Training Center to Improve Community-Based Diabetes Care
10. BioCrossroads Launches www.biocrossroadslinx.com and Releases Report on Biopharma Discovery and Development Contract Services
11. ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator (YI) ... of the Class of 2016 were selected from a pool of 128 applicants ... the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):